The new
BIOFIRE^®SPOTFIRE^® Respiratory Solution

5 Targets or 15 Targets—You Decide

An evolving world deserves evolved diagnostics. As the leader in syndromic PCR testing, bioMérieux has evolved our point-of-care respiratory testing solution by developing new products with clinicians and their patients in mind. bioMérieux is pleased to announce a revolutionary portfolio of versatile, lab-grade respiratory PCR tests, the BIOFIRE^® SPOTFIRE^® Respiratory (R) Panel Mini and BIOFIRE^® SPOTFIRE^® Respiratory (R) Panel, which give clinicians targeted and expanded syndromic options as they care for a variety of patients. These tests run on a new, fast, easy-to-use BIOFIRE^® SPOTFIRE^® System.

Experience the new BIOFIRE SPOTFIRE System

BIOFIRE^® SPOTFIRE^® Respiratory (R) Panel Mini

1 PCR Test. 5 Targets. ~15 Minutes.

The SPOTFIRE R Panel Mini brings the power of targeted syndromic testing via lab-quality PCR results to the front line. It tests for the 5 most probable viruses that cause respiratory tract infections, including influenza, rhinovirus, respiratory syncytial virus, and SARS-CoV-2. This panel runs on the easy-to-use SPOTFIRE System, which provides results in about 15 min.

GET A QUOTE

SPOTFIRE RESPIRATORY PANEL MINI MENU

Sample Type: Nasopharyngeal swab in 1-3 mL of viral transport media
Hands-on time: 1-2 minutes

VIRUSES:

Coronavirus SARS-CoV-2
Human rhinovirus
Influenza A virus
Influenza B virus
Respiratory syncytial virus

SPOTFIRE Respiratory Panel

1 PCR Test. 15 Targets. ~15 Minutes.

The SPOTFIRE R Panel brings diagnostic power to clinicians via a lab-grade, PCR-based expanded syndromic approach. In other words, the SPOTFIRE R Panel combines symptom-driven testing for a broad grouping of probable respiratory pathogens into one rapid test that aids in the diagnosis of patients experiencing signs or symptoms of respiratory tract infections, maximizing the change of getting an actionable answer in a clinically relevant timeframe.

GET A QUOTE

SPOTFIRE RESPIRATORY PANEL MENU

Sample Type: Nasopharyngeal swab in 1-3 mL of viral transport media
Hands-on time: 1-2 minutes
Overall Peformance:¹ PPA: 98.5%, NPA: 99.1%
SARS-CoV-2 Performance:¹ PPA: 97.3%, NPA: 99.4%

VIRUSES:

Adenovirus
Coronavirus SARS-CoV-2
Coronavirus (seasonal)
Human metapneumovirus
Human rhinovirus/enterovirus
Influenza A virus
- Influenza A virus A/H1-2009
- Influenza A virus A/H3
Influenza B virus
Parainfluenza virus
Respiratory syncytial virus

BACTERIA:

Bordetella parapertussis
Bordetella pertussis
Chlamydia pneumoniae
Mycoplasma pneumoniae

SPOTFIRE System

The SPOTFIRE System is the latest advancement in molecular infectious disease diagnostics. It is designed to run the SPOTFIRE R Panels.

Requires minimal benchtop space and can be scaled vertically, up to four modules, enabling customizable throughput
Module random access allows the ability to run up to 4 tests at the same time
Easy to use with an intuitive system interface and streamlined workflow
Can be used by any healthcare professional in any healthcare setting
Seamlessly connects with point-of-care data management systems and other compatible systems and software

REQUEST A DEMO

1. Calculation based on running the BIOFIRE^® SPOTFIRE^® R PANELS (~15 minutes) in an 8 hour shift.

Rethink the Power of Diagnostics with the SPOTFIRE Respiratory Solution to Potentially:

Inform Clinical Decisions

High sensitivity, specificity, and reliability provides results clinicians can trust
Contrary to tests that only detect the flu, SARS-COV-2, and/or RSV, an expanded syndromic panel provides a fuller picture which may help inform patient management decisions

Optimize Operations

The simplified workflow and quick turnaround time enable rapid and definitive answers during the patient visit, while reducing the need for callbacks or expensive and slow send-out testing
This easy-to-use solution enables users of all skill levels to prepare and run samples

Optimize Antimicrobial
Stewardship

Receiving comprehensive, definitive results in a clinically actionable timeframe may inform diagnoses while optimizing care and antimicrobial stewardship

Improve Patient Satisfaction

Using the right test, the first time to detect multiple pathogens may result in reduced follow-up appointments, swabbing, and testing, which could improve patient comfort, experience, and convenience

How to Order

To order the BIOFIRE SPOTFIRE Respiratory Panel or BIOFIRE SPOTFIRE System, contact your sales representative or use the following contact information:

Email: insidesales@biomerieux.com
Phone: 1-801-736-6354
US Sales Extension: 1502
International Sales Extension: 1536

GET PRICING

Product Information:

PRODUCT NAME	PART NUMBER	QUANTITY
BIOFIRE SPOTFIRE Respiratory Panel Kit	424461	30-Pack
SPOTFIRE RSP Pos & Neg Controls	M425	2 boxes (1 x M42638, 1 x M42738)
SPOTFIRE RSP Positive Controls	M42638	1 box (6 tubes)
SPOTFIRE RSP Negative Controls	M42738	1 box (6 tubes)
NATtrol^TM Respiratory Verification Panel	NATRSP-BIO	1 Panel
NATtrol™ Respiratory Verification Panel Mini	NATRMP-BIO	1 Panel
BIOFIRE SPOTFIRE Respiratory Panel, Verification Kit	424595	1 x NATRSP-BIO, 5 x M425, 3 x 424461
BIOFIRE SPOTFIRE Respiratory Panel Mini, Verification Kit	424596	1 x NATRMP-BIO, 5 x M425, 3 x 424461
BIOFIRE SPOTFIRE Control Station	FAST-ASY-0001	1
BIOFIRE SPOTFIRE Module	FAST-ASY-0002	1

Don’t Guess. Know.

The typical symptoms of a respiratory infection can be caused by many viruses and bacteria. Remove the guesswork with syndromic testing. Our multiplex PCR technology is more sensitive than rapid antigen tests and can help inform timely optimal therapy.

Learn more about syndromic infectious disease testing.

Product availability varies by country. Consult your bioMérieux representative.

Reference:

1. Overall performance and SARS-CoV-2 performance based on the prospective clinical study for the BIOFIRE SPOTFIRE Respiratory Panel.

The new BIOFIRE® SPOTFIRE® Respiratory Solution